-
An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening
Mar 10, 2025, 14:00 PM -
The Importance of Medicare Advantage Plan Design and Impact on Health Equity
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Clinical Characteristics Among Patients With Crohn’s Disease Receiving First- and Second-Line Biologic Treatments in The United States
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and the Economic Burden of Neovascular Age-Related Macular Degeneration (nAMD): A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Prevalence of Diabetes and Its Impact on Hospitalization among Patients with Cancer: A Population-Based Study in the U.S.
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Integrating Artificial Intelligence-Based Retinal Photographic Cardiovascular Disease risk Assessment with Diabetic Retinopathy Screening Programmes: A Multi-Country Analysis
Mar 10, 2025, 14:00 PM -
Glucocorticoid Exposure and the Risk of Serious Infections in CIDP
Mar 10, 2025, 14:00 PM -
Development of a Conceptual Model of the Patient Experience with Idiopathic Hypersomnia: Patient Interviews from a Clinical Trial (NCT05156047)
Mar 10, 2025, 14:00 PM -
Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada
Mar 10, 2025, 14:00 PM -
Disparities in Access to COPD Medications in Brazil - Impact of Geography and Socioeconomic Factors on Patient Travel Distances
Mar 10, 2025, 14:00 PM -
Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia
Mar 10, 2025, 14:00 PM -
Are Workforce Productivity Measures Useful for Formulary Management Decision-Making?
Mar 10, 2025, 14:00 PM -
2015-2024 Pricing Advantage of First-in-Indication Non-Oncology Orphan Products Versus Late Entrants and Recent Trends
Mar 10, 2025, 14:00 PM -
Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency
Mar 10, 2025, 14:00 PM -
Risk of Developing Diabetic Retinopathy and Diabetic Macular Edema in Patients With Insulin Therapy Vs Newer Oral Hypoglycemic Agents (SGLT2i and GLP-1)
Mar 10, 2025, 14:00 PM -
The Burden of Migraine in Brazil's Private Healthcare System: Results From the Brazil Migraine Real-World Evidence (BREM) Study
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review of the Economic Burden in Patients with Ehlers-Danlos Syndrome in the United States
Mar 10, 2025, 14:00 PM -
From Scarcity to Strategy: Generative AI for Rare Disease Model Conceptualization
Mar 10, 2025, 14:00 PM -
Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO
Mar 10, 2025, 14:00 PM
